| Literature DB >> 21991995 |
Daniel Seeliger, Szabolcs Soeroes, Rebecca Klingberg, Dirk Schwarzer, Helmut Grubmüller, Wolfgang Fischle.
Abstract
In cases where binding ligands of proteins are not easily available, structural analogues are often used. For example, in the analysis of proteins recognizing different methyl-lysine residues in histones, methyl-lysine analogues based on methyl-amino-alkylated cysteine residues have been introduced. Whether these are close enough to justify quantitative interpretation of binding experiments is however questionable. To systematically address this issue, we developed, applied, and assessed a hybrid computational/experimental approach that extracts the binding free energy difference between the native ligand (methyl-lysine) and the analogue (methyl-amino-alkylated cysteine) from a thermodynamic cycle. Our results indicate that measured and calculated binding differences are in very good agreement and therefore allow the correction of measured affinities of the analogues. We suggest that quantitative binding parameters for defined ligands in general can be derived by this method with remarkable accuracy.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21991995 PMCID: PMC3265130 DOI: 10.1021/cb200363r
Source DB: PubMed Journal: ACS Chem Biol ISSN: 1554-8929 Impact factor: 5.100
Figure 1Comparing interaction of methyl-lysine binding domains (BD) with methyl-lysine (Kme) and methyl-lysine analogues (KCme) containing peptides. (a, b) Structural parameters of Kme and KCme. (c) Experimental scheme for measurement and calculation of ΔΔG values in a thermodynamic cycle. The difference in binding free energy between the BD*Kme-pep and BD*KCme-pep complexes can be assessed by alternate routes: experimentally via ΔG2 – ΔG1 or computationally via ΔG4 – ΔG3. In the nonequilibrium thermodynamic integration runs the λ = 0 state of the complex is represented by BD*Kme-pep and the λ = 1 state is represented by BD*KCme-pep.
Figure 2Structural details of methyl-lysine (derived from the PDB entries, in gray) and corresponding methyl-lysine analogues (in purple with the sulfur in yellow) containing BD*pep complexes as used for the λ = 0 and λ = 1 states of the calculation are depicted for (a) Su(Var)205 Chromo domain/H3K9me3 (PDB code 1kne), (b) L3MBTL1 3xMBT/H4K20me1 (PDB code 2rhy), (c) ING1 PHD finger/H3K4me3 (PDB code 2qic), and (d) ICBP90 pseudo Tudor/H3K9me3 (PDB code 3db3). Histone peptide backbones are represented by ribbon diagrams. Protein domains are given as van der Waals surfaces. Note that the peptide backbone of H4K20me1 (residues 15–25) in the L3MBTL1 3xMBT complex was added in the absence of structural details.
Measured and Calculated Binding Free Energy Differences (ΔΔG) of Interaction of the Indicated Proteins/Domains with Different Methylated Histone Tail Peptides
| protein | PDB | domain | site | method | Δ | Δ | ΔΔ | ΔΔ | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Su(Var)205 | Chromo | H3K9me3 | ITC | 0.3 ± 0.0 | –37.6 ± 0.2 | 1.6 ± 0.1 | –33.1 ± 0.2 | 4.5 ± 0.2 | 7.3 ± 0.4 | |
| ING1 | PHD finger | H3K4me3 | FP | 16.2 ± 4.4 | –27.3 ± 0.7 | 11.4 ± 2.3 | –28.2 ± 0.5 | –0.9 ± 0.8 | –0.6 ± 0.4 | |
| L3MBTL1 | 3xMBT | H4K20me1 | FP | 6.2 ± 0.5 | –29.7 ± 0.2 | 48.2 ± 3.0 | –24.6 ± 0.2 | 5.1 ± 0.3 | 6.1 ± 0.5 | |
| ICBP90 | pseudo Tudor | H3K9me3 | FP | 0.4 ± 0.1 | –36.7 ± 0.5 | 0.4 ± 0.1 | –36.7 ± 0.7 | 0.0 ± 0.8 | –1.2 ± 0.3 | |
| 53BP1 | Tudor | H4K20me2 | FP | 18.1 ± 2.8 | –27.0 ± 0.4 | 2.7 ± 0.4 | ||||
| hHP1α(CBX5) | Chromo | H3K9me3 | 7.3 ± 0.4 | |||||||
| hHP1β(CBX1) | Chromo | H3K9me3 | FP | 1.9 ± 0.5 | –32.7 ± 0.7 | 11.6 ± 3.9 | –28.2 ± 0.8 | 4.6 ± 1.1 | ||
| hHP1γ(CBX3) | Chromo | G9aK165me3 | 7.3 ± 0.4 |
Apparent molar dissociation constants (Kd) for the different methyl-lysine binding domains were derived from isothermal calorimetry (ITC) or fluorescence polarization (FP) measurements for methyl-lysine (Kme) and methyl-lysine analogues (KCme) containing peptides.
Not binding.
Not determined.
Figure 3Comparison of experimental and calculated ΔΔG values for different BD*Kme-pep and BD*KCme-pep complexes.
| H3(1–15)K4me3-Fl | ARTK(me3)QTARKSTGGKA-fluoresceine |
| H3(1–15)KC4me3-Fl | ARTKC(me3)QTARKSTGGKA-fluoresceine |
| Fl-H3(1–15Y)K9me3 | fluoresceine-ARTKQTARK(me3)STGGKAY |
| Fl-H3(1–15)KC9me3 | fluoresceine-ARTKQTARKC(me3)STGGKA |
| Fl-H4(12–27Y)K20me1 | fluoresceine-KGGAKRHRK(me1)VLRDNIQY |
| Fl-H4(12–27)KC20me1 | fluoresceine-KGGAKRHRKC(me1)VLRDNIQ |
| Fl-H4(12–27Y)K20me2 | fluoresceine-KGGAKRHRK(me1)VLRDNIQY |
| Fl-H4(12–27)KC20me2 | fluoresceine-KGGAKRHRKC(me1)VLRDNIQ |
| H3(1–15Y)K9me3 | ARTKQTARK(me3)STGGKAY |
| H3(1–15Y)KC9me3 | ARTKQTARKC(me3)STGGKAY |